
GLUE Market Capitalization Overview
Market Cap: $302.02M as of Jun 13, 2025
$302.02M
Past Month+$74.43M (32.70%)
As of Jun 13, 2025, GLUE has a market capitalization of $302.02M. Over the past 30 days, its market cap has decreased by -8.16%, while in the last 12 months, it has decreased by -29.17%.
Market capitalization represents the total value of Monte Rosa Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GLUE Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GLUE helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Monte Rosa Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GLUE Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GLUE helps investors assess the company's size and compare it with competitors for better investment decisions.
GLUE Market Cap & Key Trends
See Monte Rosa Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in GLUE
Order type
Buy in
Order amount
Est. shares
0 shares
GLUE Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $276.80M | -8.16% |
May 1, 2025 | $301.40M | +10.61% |
Apr 1, 2025 | $272.49M | -20.09% |
Mar 3, 2025 | $340.98M | -14.75% |
Feb 3, 2025 | $399.96M | -8.44% |
Jan 2, 2025 | $436.82M | -30.43% |
GLUE End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $302.02M | -29.17% |
2024 | $426.38M | +50.68% |
2023 | $282.96M | -23.18% |
2022 | $368.32M | -61.22% |
2021 | $949.66M | — |
FAQs About Monte Rosa Therapeutics (GLUE) Market Cap
As of Jun 13, 2025, the market capitalization of GLUE is $302.02M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Monte Rosa Therapeutics’s market capitalization has increased by 32.70%, changing from $227.59M to $302.02M as of Jun 13, 2025.
In the last 3 months, Monte Rosa Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Monte Rosa Therapeutics’s market capitalization increased from $282.96M in January to $426.38M in December, reflecting a 50.68% change.
In the past five years, GLUE has had a compound annual growth rate (CAGR) of -18.14% in market capitalization. This means its market cap has shrunk at an average rate of -18.14% per year.